Australasian paediatric gastroenterologist practices of coeliac disease diagnosis before and during the COVID‐19 pandemic

Autor: Shaun S C, Ho, Helen M, Evans, Amin J, Roberts, Nikhil, Thapar, Shoma, Dutt, Kunal, Thacker, Usha, Krishnan, Chee Y, Ooi, Jason, Yap, Ajay, Sharma, Andrew S, Day
Rok vydání: 2022
Předmět:
Zdroj: Journal of Paediatrics and Child Health. 58:2280-2285
ISSN: 1440-1754
1034-4810
DOI: 10.1111/jpc.16227
Popis: To explore the perceptions and practices of Australasian paediatric gastroenterologists in diagnosing coeliac disease (CD) before and during the COVID-19 pandemic.Paediatric gastroenterologists in Australasia were invited via email to complete an anonymous online questionnaire over a 2-week period in 2021.The questionnaire was completed by 39 respondents: 33 from Australia and six from New Zealand (NZ) equating to a 66% response rate. Thirty-four (87%) of the 39 respondents reported they currently practised non-biopsy diagnosis of CD in eligible children, while the rest diagnosed CD using biopsy confirmation only. All NZ respondents practised non-biopsy CD diagnosis. A majority of responders (76%) who practised non-biopsy CD diagnosis followed the 2020 European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) guidelines. Twenty-two (56%) respondents reported that they started using a non-biopsy CD diagnosis protocol before the pandemic and did not change their practice during the pandemic, 10 (26%) started diagnosing non-biopsy CD during the pandemic, 5 (13%) stated their practices of CD were not impacted by the pandemic and 2 (5%) did not respond on whether the pandemic changed their practice.The majority of Australasian gastroenterologist respondents reported they routinely utilised the 2020 ESPGHAN diagnostic criteria in eligible children; half of them started prior to the pandemic and another quarter started this approach due to the pandemic. A minority of practitioners routinely rely only on biopsy confirmation to diagnose CD.
Databáze: OpenAIRE